Inhibiting the NFκB Activity with GTCpFE in Breast Cancer Cells
7:22
Inhibiting Breast Cancer Stem Cells with GTCpFE In Vitro
10:11
Results: GTCpFE Inhibits the NFκB Pathway, Mammosphere Formation, and the CD44+CD24- Immunophenotype in Breast Cancer Cells
11:49
Conclusion
Transcription
The overall goals of this procedure are to demonstrate how the anti-inflammatory aspirin-fumarate prodrug GTCpFE is synthesized, and how it improves anti-NFkappaB and anti-cancer stem cell activity in breast cancer cells. This method can help answ
Connectez-vous ou commencez votre essai gratuit pour accéder à ce contenu.
This procedure will demonstrate how we synthesized and characterized the anti-NFκB and anti-cancer stem cell activity of an aspirin-fumarate prodrug.